Victims or Vectors References

AIDS Patient Care and STDs 2012 26:8, 444-453

Amaro H. (1995). Love, sex, and power. Considering women's realities in HIV prevention. The American psychologist, 50(6), 437–447. https://doi.org/10.1037//0003-066x.50.6.437

Arras JD. HIV and childbearing. 2. AIDS and reproductive decisions: having children in fear and trembling. Milbank Q. 1990;68(3):353-82. PMID: 2266923.

Bayer R. (1990). AIDS and the future of reproductive freedom. The Milbank quarterly, 68(Suppl. 2), 179–204

Broussard, J. (2020, February 7). Resource: Side-by-side comparison: Truvada and Descovy for Prep. San Francisco AIDS Foundation. Retrieved February 3, 2023, from https://www.sfaf.org/resource-library/side-by-side-comparison-truvada-and-descovy-for-prep/

Brown, T. T., Yuhas, K., Mayer, K. H., Landovitz, R. J., Marzinke, M. A., Hendrix, C. W., Chen, Y. Q., Klingman, K. L., Chege, W., Mccauley, M. B., Gulick, R. M., & Wilkin, T. J. (2022). Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305. The Journal of antimicrobial chemotherapy, 77(2), 500–506.

https://doi.org/10.1093/jac/dkab400

Centers for Disease Control (CDC) (1983). Immunodeficiency among female sexual partners of males with acquired immune deficiency syndrome (AIDS) - New York. MMWR. Morbidity and mortality weekly report, 31(52), 697–698.

Centers for Disease Control and Prevention. (2018, October 18). HIV pre-exposure prophylaxis, by race and ethnicity - United States, 2014–2016. Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/67/wr/mm6741a3.html

Centers for Disease Control and Prevention. (2022, August 18). HIV diagnoses. Centers for Disease Control and Prevention. Retrieved November 18, 2022, from https://www.cdc.gov/hiv/group/gender/women/diagnoses.html 

Curno, M. J., Rossi, S., Hodges-Mameletzis, I., Johnston, R., Price, M. A., & Heidari, S. (2016). A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies. Journal of acquired immune deficiency syndromes (1999), 71(2), 181–188. https://doi.org/10.1097/QAI.0000000000000842

Craft, S. M., Delaney, R. O., Bautista, D. T., & Serovich, J. M. (2007). Pregnancy decisions among women with HIV. AIDS and behavior, 11(6), 927–935. https://doi.org/10.1007/s10461-007-9219-6

Faden, R. R., Geller, G., & Powers, M. (1991). Aids, women, and the next generation: Towards a morally acceptable public policy for Hiv testing of pregnant women and newborns. Oxford University Press.

Federal Register, volume 63 issue 97 (Wednesday, May 20, 1998). (n.d.). Retrieved February 4, 2023, from https://www.govinfo.gov/content/pkg/FR-1998-05-20/html/98-13091.htm

Food and Drug Administration. (2019, August 7). Descovy for PrEP - Food and Drug Administration. FDA. Retrieved February 5, 2023, from https://www.fda.gov/media/129923/download

Food and Drug Administration. Antimicrobial Drugs Advisory Committee meeting announcement. (n.d.). Retrieved February 4, 2023, from https://www.fda.gov/advisory-committees/advisory-committee-calendar/august-7-2019-antimicrobial-drugs-advisor y-committee-meeting-announcement-08072019-08072019

Geary, C. W., & Bukusi, E. A. (2014). Women and ARV-based HIV prevention - challenges and opportunities. Journal of the International AIDS Society, 17(3 Suppl 2), 19356. https://doi.org/10.7448/IAS.17.3.19356

Gilead statement on commitment to advancing Descovy for Prep™ Study in Cisgender Women & Adolescent Females. Gilead. (n.d.). Retrieved February 4, 2023, from https://www.gilead.com/news-and-press/company-statements/gilead-statement-on-commitment-to-advancing-descov y-for-prep-study-in-cisgender-women-adolescent-females

Gupta, G. R., & Weiss, E. (1993). Women's lives and sex: implications for AIDS prevention. Culture, medicine and psychiatry, 17(4), . https://doi.org/10.1007/BF01379307

Haseltine, F. P. (2005). Women's Health Research: A Medical and Policy Primer. Health Press.

“Heart Attack Symptoms in Men vs. Women Baton Rouge, Louisiana (LA), Our Lady of the Lake Regional Medical Center.” Our Lady of the Lake Regional Medical Center. Accessed May 24, 2023. https://ololrmc.com/blogs/heart-attack-symptoms-in-men-vs-women.

HIV.gov Research is changing the face of HIV for women and girls. HIV.gov. (n.d.). Retrieved February 4, 2023, from https://www.hiv.gov/blog/research-changing-face-hiv-women-and-girls

Horwitz, Rainey, "The Dalkon Shield". Embryo Project Encyclopedia (2018-01-10). ISSN: 1940-5030 http://embryo.asu.edu/handle/10776/13043. 

Johnson, M. A., & Johnstone, F. D. (1993). Hiv infection in women. Churchill Livingstone.

Kapadia, S. N., Wu, C., Mayer, K. H., Wilkin, T. J., Amico, K. R., Landovitz, R. J., Andrade, A., Chen, Y. Q., Chege, W., McCauley, M., Gulick, R. M., & Schackman, B. R. (2018). No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG

A5305. PloS one, 13(12), e0206577. https://doi.org/10.1371/journal.pone.0206577

Karim, Q. A., Archary, D., Barré-Sinoussi, F., Broliden, K., Cabrera, C., Chiodi, F., Fidler, S. J., Gengiah, T. N., Herrera, C., Kharsany, A. B. M., Liebenberg, L. J. P., Mahomed, S., Menu, E., Moog, C., Scarlatti, G., Seddiki, N., Sivro, A., & Cavarelli, M. (2022). Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention. Frontiers in immunology, 13,

1055042. https://doi.org/10.3389/fimmu.2022.1055042

Kass N. E. (1994). Policy, ethics, and reproductive choice: pregnancy and childbearing among HIV-infected women. Acta paediatrica (Oslo, Norway : 1992). Supplement, 400, 95–98. https://doi.org/10.1111/j.1651-2227.1994.tb13344.x

Kim, J. H., & Scialli, A. R. (2011). Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicological sciences : an official journal of the Society of Toxicology, 122(1), 1–6. https://doi.org/10.1093/toxsci/kfr088

Mahowald, M. B. (2006). Bioethics and women.: Across the lifespan. Oxford University Press.

Maserejian, N. N., Link, C. L., Lutfey, K. L., Marceau, L. D., & McKinlay, J. B. (2009). Disparities in physicians' interpretations of heart disease symptoms by patient gender: results of a video vignette factorial experiment. Journal of women's health (2002), 18(10), 1661–1667. https://doi.org/10.1089/jwh.2008.1007

Mastroianni, A. C., Faden, R. R., & Federman, D. D. (1994). Women and health research: Ethical and legal issues of including women in clinical studies. National Academy Press.

Mendez, K. J., Cudjoe, J., Strohmayer, S., & Han, H.-R. (2021). Recruitment and retention of women living with HIV for clinical research: A Review. AIDS and Behavior, 25(10), 3267–3278. https://doi.org/10.1007/s10461-021-03273-1

Office of Financial Management, 15 NIH Guide for Grants and Contacts § (1986).

O Murchu, E., Marshall, L., Teljeur, C., Harrington, P., Hayes, C., Moran, P., & Ryan, M. (2022). Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ open, 12(5), e048478. https://doi.org/10.1136/bmjopen-2020-048478

Person, Stulpin, C., & Stulpin i(2020, October 22). Leaving women out of study populations can cause 'great harm'. Healio. Retrieved February 4, 2023, from https://www.healio.com/news/infectious-disease/20201016/leaving-women-out-of-study-populations-can-cause-grea t-harm

Rapaport, L. (2015, October 2). Women are missing from HIV drug trials. Reuters. Retrieved November 18, 2022, from https://www.reuters.com/article/us-health-hiv-women/women-are-missing-from-hiv-drug-trials-idUSKCN0RW2E52 0151002

Rael, C. T., Martinez, M., Giguere, R., Bockting, W., MacCrate, C., Mellman, W., Valente, P., Greene, G. J., Sherman, S., Footer, K. H. A., D'Aquila, R. T., & Carballo-Diéguez, A. (2018). Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City. AIDS and behavior, 22(11), 3627–3636. https://doi.org/10.1007/s10461-018-2102-9

R. N. G. (2019, December 2). HIV affects millions of women. So why isn't a new prep drug approved for their use? Rewire News Group. Retrieved February 4, 2023, from https://rewirenewsgroup.com/2019/12/02/hiv-truvada-descovy-women/

Skerrett, P. (2019, November 22). Barring cisgender women from the DESCOVY trials was a bad call. STAT. Retrieved February 4, 2023, from https://www.statnews.com/2019/11/25/descovy-trials-excluded-cisgender-women-bad-call/

Soon, G. (G., Min, M., Struble, K. A., Chan-Tack, K. M., Hammerstrom, T., Qi, K., Zhou, S., Bhore, R., Murray, J. S., & Birnkrant, D. B. (2012). Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of Antiretroviral therapy (2000–2008). AIDS Patient Care and STDs, 26(8), 444–453. https://doi.org/10.1089/apc.2011.0278

The Lancet HIV. (2019). New prep formulation approved…but only for some. The Lancet HIV, 6(11). https://doi.org/10.1016/s2352-3018(19)30350-9

UNAIDS Global HIV & AIDS statistics - fact sheet. UNAIDS. (n.d.). Retrieved February 4, 2023, from https://www.unaids.org/en/resources/fact-sheet

Urell, A. (2022, June 3). Tuskegee syphilis experiment. Equal Justice Initiative. https://eji.org/news/history-racial-injustice-tuskegee-syphilis-experiment/

“Update: AIDS among Women -- United States, 1994.” Centers for Disease Control and Prevention, September 19, 1998. https://www.cdc.gov/mmwr/preview/mmwrhtml/00035899.htm.

Vargesson, N., & Stephens, T. (2021). Thalidomide: History, withdrawal, Renaissance, and safety concerns. Expert Opinion on Drug Safety, 20(12), 1455–1457. https://doi.org/10.1080/14740338.2021.1991307

Walker, M. (2019, March 7). Truvada meets its match for prep. Medical News. Retrieved February 4, 2023, from https://www.medpagetoday.com/meetingcoverage/croi/78422

Walker, M. (2019, August 6). Descovy promising as prep in MSM, but may have a woman problem. Medical News. Retrieved February 4, 2023, from https://www.medpagetoday.com/infectiousdisease/hivaids/81460

Wikipedia Foundation. (2022, October 13). Oni Blackstock. Wikipedia. Retrieved February 4, 2023, from https://en.wikipedia.org/wiki/Oni_Blackstone